Autotaxin/NPP2, a secreted lysophospholipase-D, promotes cell proliferation, survival and motility by generating the signalling molecule lysophosphatidic acid. Here we show that NPP2 is N-glycosylated on N53, N410 and N524. Mutagenesis and deglycosylation experiments revealed that only the glycosylation of N524 is essential for the expression of the catalytic and motilitystimulating activities of NPP2. The N-glycan on N524 was identified as Man 8/9 GlcNAc 2 , which is rarely present on mature eukaryotic glycoproteins. Additional studies show that this N524-linked glycan is not accessible to α-1,2-mannosidase, suggesting that its nonreducing termini are buried inside the folded protein. Consistent with a structural role for the N524-linked glycan, only the mutation of N524 augmented the sensitivity of NPP2 to proteolysis and increased its mobility during Blue-Native PAGE. N524 is phylogenetically conserved and maps to the catalytic domain of NPP2, but a structural model of this domain suggests that N524 is remote from the catalytic site. Our study defines an essential role for the N524-linked glycan chain of NPP2.
INTRODUCTION
Autotaxin, also known as NPP2, is an enzyme of about 125 kDa that is secreted by various cell types in vertebrates (1, 2) . It belongs to the sevenmember family of ectonucleotide pyrophosphatases/phosphodiesterases (NPPs).
While some NPPs (NPP1, NPP3) preferentially hydrolyze nucleotides, others (NPP2, NPP6, NPP7) favour lipid phosphodiesters as substrates. NPP2 functions as the major extracellular lysophospholipase-D. Its only firmly established physiological substrate is lysophosphatidylcholine, which is cleaved into lysophosphatidic acid (LPA) and choline. LPA is an important signalling molecule that promotes the proliferation, survival and motility of cells mainly via the G-protein coupled receptors LPA 1 and LPA 2 , and is likely to mediate most, if not all, of the biological effects of NPP2 in health and disease (1, (3) (4) (5) . NPP2 is required for angiogenesis during development, as is nicely illustrated by the embryonic lethality of NPP2 null mice, which is associated with a deficient blood vessel formation (6, 7) . NPP2 has also been linked to tumour metastasis because its expression is increased in several cancers including breast cancer, glioblastoma multiforme and Hodgkin's lymphoma, and the invasiveness of the tumour cells correlates with the circulating concentration of NPP2 (8, 9, 10) . The presumed metastasis-enhancing role of NPP2 can be accounted for by its motility-stimulating and angiogenic effects. Finally, NPP2 may play a role in the etiology of multiple sclerosis, possibly because it modulates the interaction of oligodendrocytes with their extracellular matrix, thereby initiating myelination (11, 12) . NPP2 is structurally most related to NPP1 and NPP3. All these NPP isozymes have a catalytic domain that is N-terminally flanked by two somatomedin-B like domains and C-terminally by a nuclease-like domain, but the exact function of these non-catalytic domains is not yet known (2, 13, 14) . NPP2 is a secreted protein that is synthesized as a pre-pro-enzyme, while NPP1 and NPP3 are largely transmembrane ecto-enzymes. The activity of NPP2 is moderately increased by removal of the pro-peptide by furin-like proteases (15, 16) . NPP1 and NPP2 are both regulated through product inhibition by AMP and lysophosphatidic acid, respectively (17) . It is also known that NPPs, including NPP2 (18) , are glycoproteins but the nature and functions of these glycosylations have not been studied yet in detail, except for NPP7 where an enzymatic deglycosylation was found to be associated with a loss of enzymatic activity (19) . It has also been reported that NPP5 contains a high-mannose type glycan but the exact structure and function of this glycan has not been analyzed (20) . In the current study, we have mapped the glycosylation sites of NPP2 and demonstrate that the glycan chain of N524, which was identified as Man 8/9 GlcNAc 2 , has a structural function and is essential for the expression of enzymatic activities by NPP2.
MATERIALS AND METHODS
NPP2 constructs -Wild-type NPP2 (NPP2-Wt) was obtained by cloning rat NPP2 (accession number: AAH81747) in the EGFP-N 1 vector (Clontech). The EGFP-tag at the Cterminus was replaced by a c-Myc tag, and an HA-tag was introduced at the N-terminus. Sitedirected mutagenesis of the putative glycosylation sites of HA-NPP2-Myc was performed using the QuickChange TM kit (Stratagene). The sequence of the primer sets used is available upon request. All constructs were verified by sequencing.
Cell culture -HEK293T, A2058 melanoma cells and NIH-3T3 cells were maintained at 37°C under a humidified atmosphere containing 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% (v/v) heatinactivated foetal bovine serum, glucose (4.5 g/l), penicillin (100 units/ml) and streptomycin (100 µg/ml). Cells were transiently transfected at 30-40% confluency using linear polyethylenimine of 25 kDa (Polysciences, Warrington, PA). The medium was collected 72h post-transfection and cleared by centrifugation at 1000 x g for 15 minutes. The cells were harvested 72h after transfection, washed once in phosphate-buffered saline (PBS) and lysed in 50 mM Tris/HCl at pH 7.5, 0.5 mM phenylmethanesulphonyl fluoride, 0.5 mM benzamidine, 150 mM NaCl and 1% (v/v) Triton X-100. The supernatant obtained after ultracentrifugation (30 minutes at 100,000 x g) was used as 'cell lysate'. Aliquots of the cell lysates and media were used for immunoblot analysis and the assay of NPP2-associated activities. NPP2-Myc mutants were purified from the conditioned medium of HEK293T cells that were kept in medium that only contained 5% foetal bovine serum. 72h after transfection the medium was collected, cleared by centrifugation (15 minutes at 1000 x g) and the NPP2-Myc fusions were purified by affinity chromatography on anti-c-Myc that was covalently bound to CNBr-activated Sepharose (15) .
Assay
of NPP2 activities -Lysophospholipase-D activities (LPaseD) were measured by incubating aliquots of media, cell lysates or purified NPP2-Myc fusions with 2 mM (final) of the substrate lysophosphatidylcholine (14:0) at 37°C in a total volume of 40 µl. Subsequently, the released choline was quantified spectrophotometrically at 540 nm after incubation for 5 minutes with 50 µl of the peroxidase reagent (50 mM Tris at pH 9.0, 2 mM N-ethyl-N-(2-hydroxy-3-sulfoproryl)-3-methylaniline (TOOS), 5 U/ml peroxidase and 0.01% (V:V) of Triton X-100) and of the choline oxidase reagent (50 mM Tris at pH 9.0, 2 mM aminoantipyrine, choline oxidase (5 U/ml) and 0.01% Triton X-100) (21) .
Nucleotide phosphodiesterase activities (PDEase) were determined from the release of pnitrophenolate from p-nitrophenyl thymidine 5'-monophosphate (21) . Briefly, the samples were incubated at 37°C with 5 mM of the substrate, 5 mM CaCl 2 , 5 mM MgCl 2 and 100 mM Tris/HCl at pH 9.0 in a total volume of 35 µl. The reaction was stopped by the addition of 200 µl of 3 % (v/v) trichloroacetic acid. Subsequently, the mixture was neutralized with NaOH and pnitrophenolate was quantified colorimetrically at 405 nm.
The LPase D and PDEase activities of NPP2 after pre-treatment with N-glycosidase F or endoglycosidase H (Figs. 1 and 5) , and the corresponding controls (NPP2 with heatinactivated enzymes) were done in the presence of 5mM CaCl 2 and 5 mM ZnCl 2 , to counteract inhibition of NPP2 by EDTA that was present in the glycosidase preparations.
The cell motility stimulating activities of affinity-purified NPP2 mutants was studied using a 48-well Boyden chemotaxis chamber (Neuroprobe). Cells were harvested using a trypsin/EDTA solution, resuspended in DMEM, supplemented with 0.05% (v/v) bovine serum albumin (Gentaur, Belgium) and left for recovery for 1h at 37°C. Meanwhile, the bottom wells were filled with varying concentrations of the NPP2-Myc fusions diluted in PBS supplemented with 10 µM lysophosphatidyl choline (LPC C14:0) and 0.05% (v/v) bovine serum albumin (Gentaur, Belgium). The upper and lower chambers were separated by a polyvinylpyrolidone-free polycarbonate membrane (8-µm pore; Neuroprobe) coated with 0.02% fibronectin (Sigma). Subsequently, 5.10 4 cells were loaded into each upper well. After an incubation of the assembled chambers for 240 min at 37°C in a 5% CO 2 humidified incubator, the non-migrated cells in the upper compartments were removed and the cells that had migrated through the membrane were stained with the 'Diff-Quik' procedure (Medion Diagnostics, Düdingen) and counted under the light microscope at X 200 (medium power field). For each condition, five randomly chosen fields were counted. The basal migration of the NIH-3T3 cells was determined in the absence of NPP2 and subtracted from the number of cells that migrated in response to NPP2.
Electrophoresis and immunoblotting -
Proteins were separated by SDS-PAGE using 3-8% Tricine gels, transferred to polyvinylidene difluoride membranes (Amersham) and subjected to 60 V for 2h in 192 mM glycine, 25 mM Tris and 10% methanol (pH 8.6). After blotting, nonspecific binding sites were blocked with 3% bovine serum albumin (Serva) and 0.1% Tween-20 in PBS. Following overnight incubation with anti-Myc (clone 9E10) monoclonal anibodies, the Myc-tagged fusion proteins were visualized using horseradish-peroxidase-goat anti-mouse IgG (Dako) and enhanced chemiluminesence (Perkin Elmer, Boston, MA).
Blue-native (BN) PAGE was performed according to the method of Schägger and Jagow (22) , with the following modifications. A 6% polyacrylamide gel, containing 66.7 mM 6-aminocaproic acid and 50 mM Bis-tris at pH 7.0 was run for 30 min at 80 V. Subsequently, the electrophoresis was continued at 200 V until the tracking line of Coomassie blue G-250 reached the edge of the gel. As cathode buffer 50 mM Tricine, 15 mM Bis-tris, and 0.02 % Coomassie blue G-250 (pH 7.0) was used. The anode buffer contained 50 mM Bis-tris at pH 7.0. Medium samples were loaded in BN-sample buffer containing 25 mM 6-aminocaproic acid, 5 mM Bis-tris and 5% glycerol at (pH 7.0). Immunoblotting was performed as described above, except that 0.01 % SDS was added to the blotting buffer.
Purification and enzymatic treatments of melanoma NPP2 and NPP2-fusions -The conditioned medium of HEK293T cells was concentrated 10-fold by ultrafiltration (Vivaspin) and incubated overnight with anti-c-Myc Sepharose at 4°C. After washing of the beads with 20 mM Tris/HCl (pH 7.5) and 0.5 M NaCl, the retained proteins were eluted with 100 mM triethanolamine at pH 12.0. N-linked glycans were removed by overnight incubation of 30 µl of the NPP2-fusions or melanoma NPP2 at 37°C with 50 mU N-glycosidase F (10 U/ml, Roche), 0.5 % (v/v) Triton X-100, 1.3 mM phenylmethanesulphonyl fluoride and 1.3 mM benzamidine, either in the absence (nondenaturing) or presence (denaturing) of 0.1 % (v/v) SDS and 50 mM mercaptoethanol. For deglycosylation with α-1,2-mannosidase (23) or endo H (5 U/ml, Roche), the NPP2-fusions or melanoma NPP2 were incubated overnight with 10 mU of the glycosidase in the presence of 20 mM sodium acetate at pH 5.5.For trypsinolysis, affinity-purified NPP2-fusions were incubated for 30 minutes at 30°C with the indicated concentrations of trypsin. The treatment was stopped by boiling the samples for 5 minutes in the presence of 100 mM Tris, 4% (v/v) mercaptoethanol, 8% (w/v) SDS, 24% (v/v) glycerol and 0,02% (w/v) Serva blue. Subsequently, the NPP2-fusions were visualized by immunoblotting.
RT-PCR -RNA was isolated from NIH-3T3 cells using the Mammalian Total RNA Extraction kit (Sigma). Following reverse transcription with the M-MulV reverse transcriptase (Fermentas), the cDNA was PCRamplified using primers for the LPA 1 /Edg-2 receptor with TTTCACAGCCCCCAGTTCA and CATTCTCATAGTCCTCTGGCGA being the forward and the reverse primer, respectively, and for the LPA 2 /Edg-4 receptor with TGGCCTACCTCTTCCTCATGTTCC and ATTGACCAGTGAGTTGGCCT as sense and antisense primer, respectively. The PCR product was separated on an agarose gel and visualized with ethidiumbromide. Actin was used as a positive control. The specificity of the PCR reactions was evaluated by parallel incubations in the absence of RT-polymerase.
Sequencing of the glycan chains -
Determination of the glycan chains at position 524 was performed as described by Callewaert et al (24) . Briefly, 10 µg affinity purified NPP2-m1,2,3,5 was denatured by incubation for 1h at 50°C with 50 µl of a buffer containing 8 M urea, 360 mM Tris at pH 8.6 and 3.2 mM EDTA. Subsequently, the protein was bound to the PVDF membrane of a Multiscreen-IP plate (Milipore, Bedford, CA) by a gentle vacuum. Next, the bound protein was reduced and iodoalkylated, followed by the release of the glycan chains by addition of 1.25 IUBMB mU of N-glycosidase F in 20 µl of 10 mM Tris-acetate (pH 8.3) for 3h at 37°C. The glycan mixture was evaporated to dryness and a 1:1 mixture of 20 mM 8-amino-1,3,6-pyrenetrisulfonic acid (APTS; Molecular Probes, Eugene, OR) in 1.2 M citric acid and 1 M NaCNBH 3 in dimethyl sulfoxide was added. The derivatization was allowed for 18h at 37°C. After this, the reaction was quenched by the addition of 10 µl deionized water. Excess APTS was removed using a bed of Sephadex G10 packed in a Multiscreen filterplate (Milipore). After sample application, the resin beds were eluted three times by addition of 10 µl water and centrifugation for 10 seconds at 750 x g. The eluate was evaporated to dryness and reconstituted in 5 µl of deionized water. 0.4 µl aliquots of the cleaned-up derivatized glycans were incubated overnight at 37°C in 2 µl of 10 mM sodium acetate (pH 5.0) in the presence of A. ureafaciens sialidase (2 U/ml; Boehringer Mannheim, Germany), jack bean β-Nacetylhexosaminidase, D. pneumoniae β-1-4-galactosidase (1 U/ml; Boehringer Mannheim, Germany), jack bean β-N-acetylhexosaminidase (30 U/ml; Glyko), bovine epididymis α-fucosidase (0,5 U/ml; Glyko), almond fucosidase (3 mU/ml; Glyko) and recombinant Trichoderma reesei α-1,2-mannosidase, as indicated (23) . Unit definitions are as specified by the enzyme suppliers. The native as well as the digested glycan chains were analyzed using an Applied Biosystems 377A DNA sequencer (Perkin Elmer).
Modelling -The macromolecular model (Fig. 7A ) was built with DeepView 3.7SP5 (25) .
RESULTS

Mapping of the glycosylation sites of NPP2 -
Stracke et al. (26) showed that NPP2 binds to Concanavalin A, which is initial evidence that it is an N-glycosylated protein. Consistent with this notion, we found that the deglycosylation of Myc-tagged rat NPP2 (Fig. 1A) or human teratocarcinoma NPP2 (not shown) with Nglycosidase F increased their mobility during SDS-PAGE. The same mobility shift was detected when the N-glycosidase F treatment was performed under non-denaturing conditions (Fig.  1A) , enabling us to examine the effect of deglycosylation on the enzymatic activity of NPP2. Both the lysophospholipase-D activity and the nucleotide phosphodiesterase activity of rat (Fig. 1B ) and human NPP2 (not shown) were largely abolished by deglycosylation. The remaining activity could be sedimented with Concanavalin-A Sepharose (not illustrated), suggesting that it stemmed from incomplete deglycosylation.
The above data indicated that the Nglycosylation of NPP2 is essential for the expression of its catalytic activity. The program NetGlyc (www.Cbs.dtu.dk/services/) predicts that rat NPP2 contains five potential Nglycosylation sites, namely N53, N398, N410, N524 and N806, further also denoted as sites 1, 2, 3, 4 and 5, respectively ( Fig. 2A) . These residues are the first of the motif NxS/T, where x can be any residue and the last residue can be either Ser or Thr. Of the predicted glycosylation sites, all but site 2 are conserved in human and mouse NPP2 (not illustrated). To examine which of the predicted glycosylation sites of rat NPP2 were actually glycosylated, we first mutated each of the corresponding asparagines individually into an alanine, and examined the effects of these mutations on the mobility of NPP2 during SDS-PAGE and on its enzymatic activities (Fig. 2B ). An increased mobility during SDS-PAGE was only noted following the mutation of sites 1, 3 and 4, indicating that these are the only true glycosylation sites. Moreover, only the mutation of site 4 abolished the nucleotide and lysophospholipid phosphodiesterase activities of NPP2, showing that the glycosylation of N524 is required for the expression of catalytic activity. Next, we used the reverse mutational approach and mutated either all or all but one of the five predicted N-glycosylation sites. Compared to the mobility of NPP2 with all 5 sites mutated, a decreased mobility during SDS-PAGE was only noted when sites 1, 3 or 4 were mutated to an Asn (Fig. 2B) . This is consistent with the previous conclusion that these are the only Nglycosylated residues. Furthermore, of the latter mutants only the one with an intact site 4 was catalytically active (Fig. 2B) , confirming that only the glycosylation of this site is required for the expression of catalytic activity. It is also worth noting that the mutation of site 4 caused an accumulation of NPP2 in the cells (Fig. 2C) , amounting to 160 ± 3 % (n = 3) of the level of NPP2-Wt, suggesting that the glycosylation of N524 also contributes to the maturation and/or trafficking of NPP2. However, this represents a relatively minor effect since the accumulation of NPP2 in the culture medium, which contains more than 95% of the total pool of NPP2, was at most marginally (86 ± 24 % of the level of NPP2-Wt ; n= 3) affected by mutation of site 4, as detected by immunoblotting (Fig. 2C) . A combination of the mutation of site 4 with that of 3 other sites also resulted in an increased cellular retention of NPP2, except for NPP2-m1,2,3,4 which, however, also accumulated somewhat less in the medium, indicating that it represents a mutant that is less well expressed (Fig. 2C) .
Next, we examined whether the Nglycosylation of NPP2 is required for its cell motility-stimulating capability. Since the latter activity of NPP2 is mainly mediated by the LPA 1 receptor, and to a lesser extent by the LPA 2 receptor (5), we first identified cells that express these LPA receptors. Consistent with a report by Fischer et al (27) , we found by RT-PCR that NIH-3T3 fibroblasts express both the LPA 1 and LPA 2 receptor (not illustrated), making these cell suitable for our motility studies. Subsequently, we have used affinity-purified NPP2 (mutants) as chemoattractants for NIH-3T3 cells in Boyden chambers (Figs. 3A and B) . While NPP2-Wt, NPP2-N53A and NPP2-N410A were equally efficient chemoattractants, NPP2 with sites 1-5 mutated (NPP2-(m1-5)) and NPP2-N524A did not measurably stimulate cell motility, demonstrating that the N-glycosylation of N524 is essential for NPP2 to act as a chemoattractant.
Asn524
of NPP2 contains an oligomannosidic side chain -To examine the structure of the essential glycan side chain of site 4, we used affinity-purified NPP2-m1,2,3,5, which is only glycosylated on N524 (site 4). After an incubation of this NPP2 mutant with Nglycosidase F, the released glycans were labelled fluorescently and analyzed by DNA sequencing equipment (24) . This analysis revealed that the native glycans had the structure Man 8 GlcNAc 2 and Man 9 GlcNAc 2 (Fig. 4A, panel 2 ), which were also detected in the reference protein RNase B (panel 10). Additional glycan structures were released by the N-glycosidase F treatment of the NPP2-m1,2,3,5 preparations, but these could be shown to be derived from the monoclonal antibodies that were used for purification and are minor contaminants of the NPP2 preparation, and sialylated glycans on contaminating proteins deriving from the culture medium (panel 11 and not shown). The identity of the N524-linked glycan as Man 8 GlcNAc 2 and Man 9 GlcNAc 2 was confirmed by the sensitivity of these glycans to digestion by α-1,2-mannosidase (panel 4).
As a final line of evidence for the presence of an oligomannosidic side chain on N524, Fig.  5A shows that a treatment of affinity-purified NPP2-m1,2,3,5 from the conditioned medium of HEK293T cells with the hybrid/high-mannosespecific endoglycosidase H or with Nglycosidase F resulted in an increased mobility during SDS-PAGE and a highly deficient catalytic activity. Again, the remaining activity could be sedimented by incubation with Concanavalin-A Sepharose (not shown), indicating that this activity was derived from incompletely deglycosylated NPP2. To rule out the possibility that the oligomannosidic side chain is an artefact resulting from the transient overexpression of NPP2, the mannose-specific glycosidase treatments were repated with the conditioned medium of NPP2-secreting A2058 melanoma cells (18) . Both the nucleotide phosphodiesterase activity and the LPaseD activity were nearly completely abolished after enzymatic deglycosylation (Fig. 5B) , and the remaining activity was retained by Concanavalin-A Sepharose (not shown).
The N524-linked glycan chain is a structural determinant of NPP2 -Oligomannosidic glycans are usually transiently present on glycoproteins in the endoplasmic reticulum, before they get further processed in the Golgi to complex or hybrid-type glycans (28) . The presence of an oligomannosidic side-chain in a mature mammalian glycoprotein indicates that this chain might contribute to the structure of the protein by forming non-covalent contacts with surrounding residues. As a result, this side-chain may no longer be accessible for the processing enzymes in the Golgi. That this applies to the glycan chain on N524 of NPP2 was initially suggested by the observation that a treatment of NPP2-m1,2,3,5 with α-1,2-mannosidase affected neither the mobility during SDS-PAGE nor the catalytic activity of this mutant (Fig. 5A) , indicating that the oligomannose side-chain on N524 is not accessible to this glycosidase. The same results were obtained for melanoma NPP2 (Fig. 5B) .
In further agreement with the notion that the glycan chain on N524 is a structural determinant, we found that NPP2-N524A was degraded by trypsin concentrations that were about 10 times lower than those needed for the degradation of wild-type NPP2 (Fig. 6A) . Interestingly, an increased sensitivity to trypsin was not seen when the other N-glycosylation sites of NPP2 were mutated, as in NPP2-m1,2,3,5, indicating that these sites do not contribute to the structure of NPP2. We also noted that the mutation of site 4 (N524), unlike the mutation of sites 1, 2, 3 and/or 5, resulted in an increased mobility of NPP2 during Blue-Native PAGE (Fig. 6B ). Since this mobility is determined by the extent of binding of the negatively charged CoomassieBlue stain (22) , which is affected by the surface to volume ratio of the protein, these results suggest that NPP2-N524A has a less compact structure than the wild type protein, accounting for the better binding of Coomassie Blue and the increased electrophoretic mobility.
Conservation of N524 in other NPPs -
Recently, the structure has been determined of a bacterial NPP that displays about 30 % sequence identity with the catalytic domain of the human NPPs (29) . Using this structure (protein databank accession 2GSU) as a template, we have generated a model of the catalytic domain of NPP2 (Fig. 7A) . This model shows that N524 is remote from the catalytic site and that the bulky N524-linked glycan is unlikely to interact directly with the catalytic site. However, it can not be excluded that the N524-linked glycan affects the conformation and accessibility of the catalytic site. Finally, we have examined whether N524 is phylogenetically conserved. N524 was conserved in NPP2 from all examined vertebrates (Fig. 7B) . Moreover, this glycosylation site was conserved in NPP1-6 but not in NPP7 (Fig. 7C) , indicating that it may represent an essential N-glycosylation site in 6 out 7 known NPP isozymes.
DISCUSSION
Glycosylation of NPP2 on N524 is functionally important -Glycosylation is an important post-translational modification that can affect the intracellular trafficking, stability and/or function of glycoproteins. We show here that NPP2 is N-glycosylated on three sites, two of which were mapped to the catalytic domain ( Figs. 1 and 2 ). Of these, only the glycosylation of N524 appears to contribute to some extent to the trafficking of NPP2 (Fig. 2C) . Similarly, the routing of NPP3 (30) and NPP7 (19) to the plasma membrane also appears to be controlled by N-glycosylation. Mutagenesis studies revealed that the N524-linked glycan of NPP2 is also required for the expression of its lysophospholipase-D as well as for its nucleotide phosphodiesterase activities (Fig. 2B ). Since the LPaseD activity of NPP2 mediates most if not all of its biological functions, it comes as no surprise that the N524-glycan was also required for the cell motility-stimulating activity of NPP2 (Fig. 3) . It is important to note that mature NPP2 (Fig. 1A) and NPP2-m1,2,3,5 ( Fig. 5A) are also inactivated by enzymatic N-deglycosylation, indicating that the N524-linked glycan is required to maintain NPP2 in an active conformation. These data do not rule out, however, that this glycan chain also contributes to the folding of NPP2 during maturation. NPP7 is also inactivated by deglycosylation or mutagenesis of N-glycosylation sites (19) . However, the activity of NPP7 is regulated by multiple N-glycosylation sites and none of these correspond to N524 of NPP2. Our results are at variance with an earlier study that did not find an effect of a pretreatment of NPP2 with Nglycosidase F on its motility-stimulating activity (18) . However, no dose-response curves were done in the latter study and it is therefore possible that effects of N-deglycosylation were missed because the motility-stimulating effects were measured at supersaturating concentrations.
Structure and function of the N524-linked glycan -
We have identified the N524-linked glycan chain by classical sequence analysis, before and after treatment with a host of glycosidases, as Man 8/9 GlcNAc 2 by exoglycosidase array sequencing (Fig. 4) . Interestingly, NPP5 from brain membranes is retained by the mannose-specific Galanthus nivalis lectin, suggesting that it may also contain an oligomannosidic glycan chain (20) .
High-mannose glycan chains are relatively rare in mature eukaryotic proteins because they are usually processed in the Golgi to complex or hybrid glycan chains (28) . Nevertheless, there are some proteins known to contain this type of 'immature' glycan chains including the neural adhesion molecule L1 (31), a neural glycoprotein (32) and the β-subunit of rabbit gastric H,KATPase (33) . The presence of some Man 8/9 GlcNAc 2 but not smaller high-mannose glycans in mature NPP2 is suggestive for partial trimming by the ER mannosidase I without further processing by the Golgi mannosidases (33) . We suggest that the N524-linked glycan of NPP2 does not undergo additional processing in the Golgi because it is no longer accessible, probably because it is a structural determinant of NPP2 and becomes (partially) buried during the folding of NPP2. Consistent with this view we find that this glycan is accessible for hydrolysis by N-glycosidase F and endoglycosidase H but not by α-1,2-mannosidase (Fig. 5A) , indicating that the non-reducing termini of the glycan are shielded.
It is intriguing that N524 is mapped to the hinge region between the catalytic and nucleaselike domain (Fig. 2A) . It is therefore tempting to speculate that the N524-linked glycan stabilizes the interaction between these two domains, which may be essential for the expression of catalytic activity. In accordance with this interpretation we found that NPP2 showed an increased sensitivity to trypsinolysis following the mutation of N524 (Fig. 6A) . In contrast, the mutation of sites 1, 2, 3 and 5 did not have such an effect, suggesting that the N-glycans of NPP2 do not merely sterically protect trypsinsusceptible sites. Likewise, only the mutation of N524 increased the mobility of NPP2 in BlueNative PAGE, indicating that this mutant is less structured and can bind more Coomassie Blue.
In conclusion, we have shown here that the catalytic activity of NPP2 is critically dependent on the presence of a Man 8/9 GlcNAc 2 moiety on N524, a site that is phylogenetically conserved, not only in NPP2 but also in six out of seven NPP isozymes. We suggest that this glycan chain has a structural function and is involved in the interaction between the catalytic and nucleaselike domain of NPP2. A, Affinity-purifed NPP2-Wt, NPP2-N53A, NPP2-N410A, NPP2-N524A or NPP2-(m1-5), which is mutated in all 5 predicted N-glycosylation sites, were added (400 ng/ml) to the lower wells of a 48-well Boyden chamber. A polycarbonate membrane with pores of 8 µM separated the lower wells from the upper wells that were filled with NIH-3T3 cells. After an incubation for 4h at 37°C, the cells that had migrated to the lower wells were fixed, stained according to the 'Diff-Quik' staining protocol (34) , and visualized by microscopy. B, the experiment shown in Panel B was repeated at various concentrations of the NPP2 mutants, and the graph shows the number of cells that had migrated through the membrane (means ± SE, n= 3). The basal migration of the NIH-3T3 cells was determined in the absence of NPP2 and subtracted from the number of cells that migrated in response to NPP2. FIGURE 4. Sequence of the glycan chain on NPP2-N524. A, affinity-purified NPP2-m1,2,3,5 was reduced, iodoalkylated and deglycosylated, as detailed in the Experimental Section. The released glycan chains were fluorescently labelled with 8-amino-1,3,6-pyrenetrisulfonic acid. After removal of the free label, the fluorescently labeled glycan chains were either directly sequenced or first digested with the indicated exoglycosidases before analysis. The peaks identified for NPP2-m1,2,3,5 (shown in red) correspond to Man 8 GlcNAc 2 and Man 9 GlcNAc 2 , as deduced by comparison with the known chains in the reference protein RNase B and hydrolysis with a specific α-1,2-mannosidase to the Man 5 GlcNA 2 structure. The peaks shown in yellow are contaminating glycans released from the cMyc antibodies that co-eluted with NPP2-m1,2,3,5 from the antibody affinity column. B, structure of Man 9 GlcNAc 2 . The scheme also shows the sites of hydrolysis by α-1,2-mannosidase, endoglycosidase H and N-glycosidase F (GF). FIGURE 5. Inactivation of NPP2 by incubation with glycosidases. A, affinity-purified NPP2-m1,2,3,5 was treated with N-glycosidase F, endoglycosidase H or α-1,2-mannosidase under nondenaturing conditions. The figure shows the effects of these treatments on the mobility of NPP2-m1,2,3,5 during SDS-PAGE (immunoblot) and on its LPaseD and PDEase activities (bar diagram). B, LPaseD and PDEase activities in the conditioned medium from A2058 melanoma cells before and after treatment of the medium with the indicated glycosidases. The results are expressed as percentages of the activities before deglycosylation and represent means ± SE (n = 3). 
